Advances in Targeting Voltage‐Gated Sodium Channels with Small Molecules
- 4 September 2012
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 7 (10), 1712-1740
- https://doi.org/10.1002/cmdc.201200298
Abstract
Blockade of voltage‐gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathological firing patterns that occur in conditions as diverse as chronic pain, epilepsy, and arrhythmias. Herein we review the state of the art in marketed sodium channel inhibitors, including a brief compendium of their binding sites and of the cellular and molecular biology of sodium channels. Despite the preferential action of this drug class toward over‐excited cells, which significantly limits potential undesired side effects on other cells, the need to develop a second generation of sodium channel inhibitors to overcome their critical clinical shortcomings is apparent. Current approaches in drug discovery to deliver novel and truly innovative sodium channel inhibitors is next presented by surveying the most recent medicinal chemistry breakthroughs in the field of small molecules and developments in automated patch‐clamp platforms. Various strategies aimed at identifying small molecules that target either particular isoforms of sodium channels involved in specific diseases or anomalous sodium channel currents, irrespective of the isoform by which they have been generated, are critically discussed and revised.Keywords
This publication has 323 references indexed in Scilit:
- Binding Modes of μ-Conotoxin to the Bacterial Sodium Channel (NaVAb)Biophysical Journal, 2012
- Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to painEuropean journal of pain, 2011
- Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury painPharmacology Biochemistry and Behavior, 2010
- Temporal lobe epilepsy induces intrinsic alterations in Na channel gating in layer II medial entorhinal cortex neuronsNeurobiology of Disease, 2010
- Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutationsHuman Mutation, 2010
- Cardiac sodium channelopathiesPflügers Archiv - European Journal of Physiology, 2009
- Hoiamide A, a Sodium Channel Activator of Unusual Architecture from a Consortium of Two Papua New Guinea CyanobacteriaCell Chemical Biology, 2009
- The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the ratEpilepsy Research, 2009
- A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profileNeuropharmacology, 2007
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007